Publicaciones en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (31)

2020

  1. First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors

    Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042

  2. Immunotherapy with CAR-T cells in paediatric haematology-oncology

    Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10

2019

  1. The Netrin-4/Laminin γ1/Neogenin-1 complex mediates migration in SK-N-SH neuroblastoma cells

    Cell Adhesion and Migration, Vol. 13, Núm. 1, pp. 33-40

2018

  1. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy

    Cancer Research, Vol. 78, Núm. 17, pp. 4891-4901

2016

  1. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells

    Cancer Letters, Vol. 371, Núm. 2, pp. 161-170

2015

  1. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity

    Cancer Letters, Vol. 363, Núm. 2, pp. 156-165

2014

  1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells

    Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148

  2. Dopamine mobilizes mesenchymal progenitor cells through d2-class receptors and their pi3k/akt pathway

    Stem Cells, Vol. 32, Núm. 9, pp. 2529-2538

  3. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: Correlations with the course of disease

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. A role for the CXCR3/CXCL10 axis in rasmussen encephalitis

    Pediatric Neurology, Vol. 49, Núm. 6, pp. 451-457.e1

2012

  1. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients

    International Journal of Molecular Medicine, Vol. 30, Núm. 2, pp. 365-373

2010

  1. Oncolytic virotherapy for neuroblastoma.

    Discovery medicine, Vol. 10, Núm. 54, pp. 387-393

  2. Retraction: Spontaneous human adult stem cell transformation (Cancer Research (2005) 1)

    Cancer Research

  3. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: An exploratory study

    Cancer Gene Therapy, Vol. 17, Núm. 7, pp. 476-483

2009

  1. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

    Journal of Experimental Medicine, Vol. 206, Núm. 13, pp. 3131-3141

  2. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells1 2 www.neoplasia.com

    Neoplasia, Vol. 11, Núm. 4, pp. 397-407

  3. Mobilisation of mesenchymal cells in cardiac patients: Is intense exercise necessary?

    British Journal of Sports Medicine, Vol. 43, Núm. 3, pp. 221-223

2007

  1. Early-phase adaptations to intrahospital training in strength and functional mobility of children with leukemia

    Journal of Strength and Conditioning Research, Vol. 21, Núm. 1, pp. 173-177

  2. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow

    Journal of Pediatric Hematology/Oncology, Vol. 29, Núm. 6, pp. 388-392

  3. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy

    Annals of Neurology, Vol. 61, Núm. 1, pp. 73-83